fda warning letters glp-1 compounders september 2025 Why the Issued 30 to Telehealth Sites Marketing Compounded GLP-1s September 8, 2025: FDA launches

Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J

The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes

Weight Maintenance and the Fear of Regaining Once you hit your goal weight, the fear of regaining it is real

Given the potential loss of effectiveness in Gs signalling in diabetic conditions and that both GIP and GCG seem to primarily act through Gs signalling, it raises a second question: is the effect of triagonist on glucose-stimulated insulin secretion (GSIS) mediated solely via GLP-1R

It sounds like, you know, the insulin metaphor I think is a little challenging because it'll literally kill you, right